Clinical Trial

Determination of Microbiological Factors Associated With Poor Response to Neoadjuvant Treatment in Rectal Cancers

Study acronym: MICARE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 12, 2025 (before its estimated January 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of this project is to determine in a non-invasive manner (fecal samples) the predictive value of the intestinal microbiota and the presence of genotoxin-producing bacteria on the response to neoadjuvant treatment in rectal cancer. This could lead to a better understanding and selection of patients for personalized treatment in rectal cancer.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2019-09-24; most recent amendment 2025-02-11.
Status change: Not Yet Recruiting → Recruiting 2020-02-24
Trial Details
NCT Number NCT04103567
Lead Sponsor Institut du Cancer de Montpellier - Val d'Aurelle
Conditions Rectal Cancer
Enrollment 220 participants
Start Date 2020-01-14
Primary Completion 2026-01-30 (estimated)
Study Completion 2030-01-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-12